Bank of America reiterates neutral on Boston Scientific (BSX)
Bank of America reiterated their neutral rating on shares of Boston Scientific in a research note issued to investors on Wednesday.
Bank of America Merrill Lynch reported on Monday that they have downgraded biopharmaceutical company, Bristol Myers Squibb Co. to ``Neutral.''